Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/26/2026 | Q4 | $22M | -- | -- | $0.15 | -- |
| 11/05/2025 | Q3 | $22.6M | $23.1M | $0.29 | $0.31 | -$0.02 |
| 08/06/2025 | Q2 | $21.4M | $21.8M | $0.18 | $0.28 | -$0.10 |
| 05/07/2025 | Q1 | $20.4M | $22M | $0.24 | $0.23 | $0.01 |
| 02/27/2025 | Q4 | $18.1M | $19.6M | $0.06 | $0.09 | -$0.03 |
| 11/06/2024 | Q3 | $18.4M | $19.1M | $0.12 | $0.23 | -$0.11 |
| 08/07/2024 | Q2 | $17.5M | $19.1M | $0.19 | $0.19 | -$0.00 |
| 05/08/2024 | Q1 | $16.6M | $17.5M | $0.13 | $0.17 | -$0.04 |
| 03/07/2024 | Q4 | -- | $15.1M | -$0.08 | -- | -- |
| 11/07/2023 | Q3 | -- | $15.8M | $0.87 | -- | -- |
| 08/07/2023 | Q2 | -- | $14.7M | $0.10 | -- | -- |
| 05/09/2023 | Q1 | -- | $14.6M | $0.05 | -- | -- |
| 03/08/2023 | Q4 | -- | $13.1M | -$0.11 | -- | -- |
| 11/07/2022 | Q3 | -- | $15M | $0.16 | -- | -- |
| 08/09/2022 | Q2 | -- | $12.5M | -$0.01 | -- | -- |
| 05/04/2022 | Q1 | -- | $12.7M | $0.01 | -- | -- |
| 03/09/2022 | Q4 | -- | $11.3M | -$0.13 | -- | -- |
| 11/09/2021 | Q3 | -- | $11.7M | $0.09 | -- | -- |
| 08/11/2021 | Q2 | -- | $10.9M | $0.13 | -- | -- |
| 05/11/2021 | Q1 | -- | $10.2M | -$0.05 | -- | -- |
| 03/10/2021 | Q4 | -- | $9M | -$0.15 | -- | -- |
| 11/10/2020 | Q3 | -- | $9.3M | -$0.08 | -- | -- |
| 08/11/2020 | Q2 | -- | $7.1M | -$0.22 | -- | -- |
| 05/11/2020 | Q1 | -- | $9.3M | -$0.13 | -- | -- |
| 12/31/2019 | Q4 | -- | $9.1M | -$0.42 | -- | -- |
| 09/30/2019 | Q3 | -- | $8.3M | -$0.09 | -- | -- |
| 06/30/2019 | Q2 | -- | $7.2M | -$0.37 | -- | -- |
| 03/31/2019 | Q1 | -- | $5.7M | -$0.13 | -- | -- |
| 12/31/2018 | Q4 | -- | $4.7M | -$0.20 | -- | -- |
| 09/30/2018 | Q3 | -- | $4.4M | -$0.12 | -- | -- |
| 06/30/2018 | Q2 | -- | $3.9M | -$0.15 | -- | -- |
| 03/31/2018 | Q1 | -- | $3.3M | -$0.20 | -- | -- |
| 12/31/2017 | Q4 | -- | $2.7M | -$0.30 | -- | -- |
| 09/30/2017 | Q3 | -- | $2.3M | -$0.17 | -- | -- |
| 06/30/2017 | Q2 | -- | $2M | -$0.61 | -- | -- |
| 03/31/2017 | Q1 | -- | $1.6M | -$0.14 | -- | -- |
| 12/31/2016 | Q4 | -- | $1.3M | -$0.18 | -- | -- |
| 09/30/2016 | Q3 | -- | $1.2M | -$0.37 | -- | -- |
Red Violet, Inc. reported $23.1M worth of top line sales in its most recent quarter.
Red Violet, Inc. announced earnings per share of $0.29 which represents a miss of analyst forecast a $0.31 per share.
Red Violet, Inc. reported $16.8M that represents $1.15 per share over the last quarter.
Red Violet, Inc.'s earnings are forecast to grow from $0.50 per share to $0.81 per share next year representing an increase of 132.96%.
Red Violet, Inc.'s next earnings date is February 26, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.